Photodynamic efficacy of hypericin targeted by two delivery techniques to hepatocellular carcinoma cells

被引:12
作者
Fadel, Maha [2 ]
Kassab, Kawser [3 ]
Youssef, Tareq [1 ]
机构
[1] Cairo Univ, Photobiosci Lab, Div Photochem & Photobiol, NILES, Giza 12613, Egypt
[2] Cairo Univ, Pharmaceut Technol Lab, Med Laser Applicat Dept, NILES, Giza 12613, Egypt
[3] Cairo Univ, Cell Photosensitizat Lab, Med Laser Applicat Dept, NILES, Giza 12613, Egypt
关键词
Photodynamic therapy; Hypericin; Drug carrier; Anti-hepatocyte specific antigen; Liposomes; Hepatocellular carcinoma; ANTIVIRAL AGENT HYPERICIN; IN-VITRO; HUMAN GLIOBLASTOMA; SINGLET OXYGEN; THERAPY; FLUORESCENCE; CANCER; PHOTOSENSITIZATION; PHOTOIMMUNOTHERAPY; LOCALIZATION;
D O I
10.1007/s10103-010-0787-8
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The photocytotoxic effect of hypericin (Hyp) targeted by two different delivery techniques, namely, liposomes and anti-hepatocyte specific antigen (anti-HSA) was investigated. Optical absorption and steady-state fluorescence were used to analyze the conjugation of Hyp with anti-HSA model and to evaluate the encapsulation capacity and drug release in a liposome model. Particle size and thermal analysis of the prepared liposomes were performed using laser-light scattering and differential scanning calorimetry (DSC), respectively. Viability study of HepG2 cells exposed to Hyp in the two delivery systems, in the dark and following visible light irradiation, was performed in comparison to free Hyp. The intracellular uptake and localization of Hyp in HepG2 cells were analyzed by means of spectrofluorometry and fluorescence microscopy. Spectroscopic measurements demonstrated that Hyp binds to anti-HSA in its monomeric form. The photocytotoxic effect of Hyp depended clearly on the form of Hyp administered, either in free form, loaded into liposomes or conjugated with anti-HSA. While liposomes loaded with Hyp (Lip-Hyp) did not induce significant phototoxicity, both free Hyp or anti-HSA-Hyp inflicted substantial cell mortality, after photoirradiation. The intracellular uptake of Lip-Hyp by HepG2 cells was estimated to be 20% less compared to free Hyp or anti-HSA-Hyp. In spite of the equal uptake of both free Hyp and anti-HSA-Hyp, HepG2 cells demonstrated a relatively higher mortality with anti-HSA-Hyp compared to free Hyp.
引用
收藏
页码:675 / 683
页数:9
相关论文
共 50 条
  • [21] Characterization of apoptosis induced by photodynamic treatment with hypericin in A431 human epidermoid carcinoma cells
    Berlanda, J
    Kiesslich, T
    Oberdanner, CB
    Obermair, FJ
    Krammer, B
    Plaetzer, K
    JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2006, 25 (1-2) : 173 - 188
  • [22] Regorafenib enhances the efficacy of photodynamic therapy in hepatocellular carcinoma through MAPK signaling pathway suppression
    Zhang, Song
    Zhang, Xiao
    Ren, Yali
    Huang, Lu
    Xu, Weitian
    Wang, Haiping
    Lu, Qiping
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2024, 49
  • [23] Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®-Based Nanoparticles Modulating Hypericin Delivery
    Zago Ferreira Damke, Gabrielle Marconi
    Souza, Raquel Pantarotto
    Montanha, Maiara Camotti
    Damke, Edilson
    Goncalves, Renato Sonchini
    Cesar, Gabriel Batista
    Kimura, Elza
    Caetano, Wilker
    Hioka, Noboru
    Lopes Consolaro, Marcia Edilaine
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2020, 20 (11) : 1352 - 1367
  • [24] Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer
    Perrone, Francesca
    Craparo, Emanuela Fabiola
    Cemazar, Maja
    Kamensek, Urska
    Drago, Salvatore Emanuele
    Dapas, Barbara
    Scaggiante, Bruna
    Zanconati, Fabrizio
    Bonazza, Debora
    Grassi, Mario
    Nhung Truong
    Pozzato, Gabriele
    Farra, Rossella
    Cavallaro, Gennara
    Grassi, Gabriele
    JOURNAL OF CONTROLLED RELEASE, 2021, 330 : 1132 - 1151
  • [25] H-TEX-mediated signaling between hepatocellular carcinoma cells and macrophages and exosome-targeted therapy for hepatocellular carcinoma
    Yu, Sihang
    Zhou, Lei
    Fu, Jiaying
    Xu, Long
    Liu, Buhan
    Zhao, Yuanxin
    Wang, Jian
    Yan, Xiaoyu
    Su, Jing
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [26] Galactosylated Chitosan Oligosaccharide Nanoparticles for Hepatocellular Carcinoma Cell-Targeted Delivery of Adenosine Triphosphate
    Zhu, Xiu Liang
    Du, Yong Zhong
    Yu, Ri Sheng
    Liu, Ping
    Shi, Dan
    Chen, Ying
    Wang, Ying
    Huang, Fang Fang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (08): : 15755 - 15766
  • [27] In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma
    Diez, Sonsoles
    Navarro, Gemma
    de ILarduya, Conchita Tros
    JOURNAL OF GENE MEDICINE, 2009, 11 (01) : 38 - 45
  • [28] Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma
    Lu, Jingxiong
    Wang, Jin
    Ling, Daishun
    SMALL, 2018, 14 (05)
  • [29] Transferrin targeted core-shell nanomedicine for combinatorial delivery of doxorubicin and sorafenib against hepatocellular carcinoma
    Malarvizhi, Giridharan Loghanathan
    Retnakumari, Archana Payickattu
    Nair, Shantikumar
    Koyakutty, Manzoor
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2014, 10 (08) : 1649 - 1659
  • [30] N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma
    Li, Tingshen
    Yu, Peng
    Chen, Yihao
    Sun, Baoying
    Dong, Peijie
    Zhu, Tao
    Meng, Xin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 222